What is POAS's health score?

Phaos Technology (Cayman) Holdings Ltd (POAS) has a TradeApes health score of 34 out of 100, rated Weak. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is POAS's estimated fair value?

Based on our 5-year discounted cash flow model, Phaos Technology (Cayman) Holdings Ltd's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is POAS undervalued or overvalued?

Our model currently rates POAS as Inconclusive. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for POAS... Refresh in a moment for the full analysis.

Phaos Technology (Cayman) Holdings Ltd (POAS)

Healthcare Inconclusive inconclusive weak

$0.36

Updated: 2026-06-05

TradeApes Score

Financial Strength

25 Stressed

Operating Trend

30 Weak

Relative Value

50 Mixed

Capital Allocation

30 Weak

Risk

35 Weak

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Sharp revenue decline — sales down more than 15% year over year

Unlock Full Report →

4 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.